A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence

American Journal of Psychiatry

Volumn 164, Issue 1, 2007, Pages 100-107

  Weiss, Roger D ^a   Griffin, Margaret L ^b   Kolodziej, Monika E ^b   Greenfield, Shelly F ^b   Najavits, Lisa M ^b   Daley, Dennis C ^b   Doreau, Heidi Ray ^b   Hennen, John A ^b  

^a MCLEAN HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

LITHIUM; VALPROIC ACID;

ADULT; ARTICLE; BEHAVIOR THERAPY; BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG DEPENDENCE; FEMALE; FOLLOW UP; GROUP THERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRIORITY JOURNAL; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SUBSTANCE ABUSE; TREATMENT OUTCOME;

EID: 33846511806     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.1.100     Document Type: Article

References (37)

1. Grant BF, Stinson FS, Dawson DA, Chou SP, Dufour MC, Compton W, Pickering RP, Kaplan K: Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Arch Gen Psychiatry 2004; 61:807-816
2. Brady KT, Casto S, Lydiard RB, Malcolm R, Arana G: Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse 1991; 17:389-397
3. Keck P, McElroy S, Strakowski S, Bourne M, West S: Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull 1997; 33:87-91
4. Dalton EJ, Cate-Carter TD, Mundo E, Parikh SV, Kennedy JL: Suicide risk in bipolar patients: the role of co-morbid substance use disorders. Bipolar Disord 2003; 5:58-61
5. Keller MB, Lavori PW, Coryell W, Andreasen NC, Endicott J, Clayton PJ, Klerman GL, Hirschfeld RM: Differential outcome of pure manic, mixed/cycling, and pure depressive episodes in patients with bipolar illness. JAMA 1986; 255:3138-3142
6. Calabrese JR, Shelton MD, Bowden CL, Rapport DJ, Suppes T, Shirley ER, Kimmel SE, Caban SJ: Bipolar rapid cycling: Focus on depression as its hallmark. J Clin Psychiatry 2001; 14(suppl): 34-41
7. Brown ES, Nejtek VA, Perantie DC, Orsulak PJ, Bobadilla L: Lamotrigine in patients with bipolar disorder and cocaine dependence. J Clin Psychiatry 2003; 64:197-201
8. Salloum IM, Cornelius JR, Daley DC, Kirisci L, Himmelhoch JM, Thase ME: Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005; 62:37-45
9. Frank E, Swartz H, Kupfer D: Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry 2000; 48:593-604
10. Miklowitz DJ, George EL, Richards JA, Simoneau TL, Suddath RL: A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder. Arch Gen Psychiatry 2003; 60:904-912
11. Lam DH, Watkins ER, Hayward P, Bright J, Wright K, Kerr N, Parr-Davis G, Sham P: A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Arch Gen Psychiatry 2003; 60:145-152
12. Colom F, Vieta E, Martinez-Aran A, Reinares M, Goikolea JM, Benabarre A, Torrent C, Comes M, Corbella B, Parramon G, Corominas J: A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Arch Gen Psychiatry 2003; 60:402-407
13. Project MATCH Research Group: Matching alcoholism treatments to client heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol 1997; 58:7-29
14. Crits-Christoph P, Siqueland L, Blaine J, Frank A, Luborsky L, Onken L, Muenz L, Thase M, Weiss R, Gastfriend D, Woody G, Barber J, Butler S, Daley D, Salloum I, Bishop S, Najavits L, Lis J, Mercer D, Griffin M, Moras K, Beck A: Psychosocial treatments for cocaine dependence: results of the National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry 1999; 56:493-502
15. Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, Lynde D, Osher FC, Clark RE, Rickards L: Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001; 52:469-476
16. Weiss RD, Griffin ML, Greenfield SF, Najavits LM, Wyner D, Soto JA, Hennen JA: Group therapy for patients with bipolar disorder and substance dependence: results of a pilot study. J Clin Psychiatry 2000; 61:361-367
17. Daley DC, Mercer D, Carpenter G: Group Drug Counseling for Cocaine Dependence. Therapy Manuals for Drug Addiction. Rockville, Md, United States Department of Health and Human Services, 2002
18. First MB, Spitzer RL, Gibbon M, Williams JBW: Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Patient Edition. New York, New York State Psychiatric Institute, Biometrics Research, 1996
19. Weiss RD, Kolodziej ME, Najavits LM, Greenfield SF, Fucito LM: Utilization of psychosocial treatments by patients diagnosed with bipolar disorder and substance dependence. Am J Addict 2000; 9:314-320
20. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Pettinati H, Argeriou M: The Fifth Edition of the Addiction Severity Index. J Subst Abuse Treat 1992; 9:199-213
21. Sobell LC, Sobell MB: Timeline follow-back: a technique for assessing self-reported alcohol consumption, in Measuring Alcohol Consumption: Psychosocial and Biochemical Methods. Edited by Litten RZ, Allen JP. Totowa, NJ, Humana Press, 1992, pp 41-72
22. Weiss RD, Najavits LM, Greenfield SF, Soto JA, Shaw SR, Wyner D: Validity of substance use self-reports in dually diagnosed outpatients. Am J Psychiatry 1998; 155:127-128
23. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, Mc-Donald-Scott P, Andreasen NC: The Longitudinal Interval Follow-up Evaluation. Arch Gen Psychiatry 1987; 44:540-548
24. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23:56-62
25. Young R, Biggs J, Ziegler V, Meyer D: A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978; 133: 429-435
26. Stata Version 8.2 for Windows (computer program) Stata Corp, College Station, Tex, 2003
27. Weiss RD, Kolodziej M, Griffin ML, Najavits LM, Jacobson LM, Greenfield SF: Substance use and perceived symptom improvement among patients with bipolar disorder and substance dependence. J Affect Disord 2004; 79:279-283
28. Drake RE, Essock SM, Shaner A, Carey KB, Minkoff K, Kola L, Lynde D, Osher FC, Clark RE, Rickards L: Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv 2001; 52:469-476
29. Randall CL, Thomas S, Thevos AK: Concurrent alcoholism and social anxiety disorder: a first step toward developing effective treatments. Alcohol Clin Exp Res 2001; 25:210-220
30. Drake RE, Yovetich NA, Bebout RR, Harris M, McHugo GJ: Integrated treatment for dually diagnosed homeless adults. J Nerv Ment Dis 1997; 185:298-305
31. Bennett ME, Bellack AS, Gearon JS: Treating substance abuse in schizophrenia: an initial report. J Subst Abuse Treat 2001; 20: 163-175
32. Hellerstein DJ, Rosenthal RN, Miner CR: Integrating services for schizophrenia and substance abuse. Psychiatr Q 2001; 72:291-306
33. Najavits L, Weiss R, Shaw S, Muenz L: "Seeking safety": outcome of a new cognitive-behavioral psychotherapy for women with postttraumatic stress disorder and substance dependence. J Trauma Stress 1998; 11:437-456
34. Brady KT, Dansky BS, Back SE, Foa EB, Carroll KM: Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: preliminary findings. J Subst Abuse Treat 2001; 21: 47-54
35. Drake RE, Xie H, McHugo GJ, Shumway M: Three-year outcomes of long-term patients with co-occurring bipolar and substance use disorders. Biol Psychiatry 2004; 56:749-756
36. Rounsaville BJ, Petry NM, Carroll KM: Single versus multiple drug focus in substance abuse clinical trials research. Drug Alcohol Depend 2003; 70:117-125
37. Rounsaville B, Weiss R, Carroll K: Options for managing psychotropic medications in drug abusing patients participating in behavioral therapies clinical trials. Am J Addict 1999; 8:178-189